Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
1.03M
-
Shares change
-
+101K
-
Total reported value, excl. options
-
$8.74M
-
Value change
-
-$137K
-
Number of buys
-
18
-
Number of sells
-
-25
-
Price
-
$8.47
Significant Holders of Greenwich LifeSciences, Inc. - COM (GLSI) as of Q2 2022
44 filings reported holding GLSI - Greenwich LifeSciences, Inc. - COM as of Q2 2022.
Greenwich LifeSciences, Inc. - COM (GLSI) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.03M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (354K shares), RENAISSANCE TECHNOLOGIES LLC (105K shares), MILLENNIUM MANAGEMENT LLC (90.3K shares), MARSHALL WACE, LLP (89.7K shares), MORGAN STANLEY (73.2K shares), BlackRock Inc. (51.1K shares), AMERIPRISE FINANCIAL INC (42.2K shares), GEODE CAPITAL MANAGEMENT, LLC (41K shares), OCCUDO QUANTITATIVE STRATEGIES LP (23.4K shares), and TWO SIGMA INVESTMENTS, LP (21.4K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.